FOUNDERS & GROWTH-STAGE

Founders and growth-stage companies — across biotech, technology and manufacturing — hit a predictable inflection point. The financial infrastructure that got them this far can no longer support the decisions ahead, the investor questions that follow, or the cadence the next round demands. I build the strategic finance capability that closes that gap.

Series A through Series C architecture: runway planning, data room design, KPI architecture, investor narrative and scenario-tested financial models — the strategic funding architecture that separates companies that raise on their terms from those that don’t.

CAC, LTV, payback, gross margin, contribution and cash conversion frameworks — designed to survive board scrutiny and give investors the rigour they expect before they ask for it. Forecast accuracy as an investor signal.

The most important financial decision a growth-stage company makes is not how much to raise — it is where to spend it. Capital allocation discipline applied across product, go-to-market, R&D and operations — so every pound funded compounds toward the next round.

A CFO who earns the founder’s trust through honest financial communication, clear commercial logic and the ability to translate complexity into decisions. Available as fractional CFO, project lead or board adviser — calibrated to your stage, your runway and your next milestone.